The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster.
Precision for Medicine, a leading provider of drug development and commercialization services, announced a strategic partnership with SOPHiA GENETICS to enhance its biomarker discovery and precision medicine services. As...
Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, announced a strategic partnership with Massive Bio, global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials, to expand patient identification capabilities and improve clinical trial enrollment across...
Xaira is an integrated biotechnology company built to deliver on the promise of artificial intelligence to help transform drug discovery and development
Xaira Therapeutics announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company’s efforts to develop AI-driven...
Plex Research, a biotechnology company using autonomous artificial intelligence (AI) to aid in drug discovery, announced that it is partnering with Ginkgo Datapoints, a service of Ginkgo Bioworks, to use the Plex AI Platform to deepen the understanding of compound treatment mechanisms of action, potentially revealing new therapeutic applications,...
Acquisition is another milestone of Siemens' ONE Tech Company program expanding the Siemens Xcelerator platform into Life Sciences software with stronger customers focus, faster innovations and higher growth
Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software based in Boston, for $5.1...
Causaly announced new scientific AI agents that provide research teams with the industry's most comprehensive biomedical knowledge for drug discovery. With agentic AI in Causaly Discover, life sciences teams can access, analyze, and synthesize information across the Causaly Knowledge Graph and internal and external data sources. Now researchers can tap into...
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing...
AZmed, one of the leading AI companies in medical imaging, announced that it has received two new U.S. Food and Drug Administration (FDA) clearances for its AI tool AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest X-rays for lung nodules and...
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By bringing together pathology teams, IT systems, and AI into a single, integrated platform, Fusion aims to eliminate workflow silos, enhance diagnostic accuracy,...
AIRA Matrix, a leading innovator in AI-driven QC solutions, and Gestalt, an industry leader in IMS and digital pathology, have formed a strategic partnership to bring AIRA Matrix's advanced AI solution, AIRAQC, to Gestalt's PathFlow. This collaboration marks a significant step toward enhancing diagnostic precision and efficiency in laboratories...
